Channel profile image
Featured Speakers
Daniel Ahn's photo
Daniel Ahn
Anthony Kerbage's photo
Anthony Kerbage
Sara Haddad's photo
Sara Haddad
Shivangini Duggal's photo
Shivangini Duggal
Talks (211)
a new triplet for BRAFV600E mCRC?
Aug 31
NCCN updates for early stage GE cancer?
Aug 27
updated OS from Keynote 585
Aug 25
CLDN18.2 and Prognostic Implications
Aug 09
NUC-1031 Negative
Aug 01
KEYNOTE-937 Negative
Aug 01
LEAP-015 Negative
Aug 01
Can we target CEACAM5 in CRC?
Aug 01
Gastric Cancer_10
Aug 01
Gastric Cancer_9
Aug 01
Gastric Cancer_8
Aug 01
Gastric Cancer_7
Aug 01
Gastric Cancer_6
Aug 01
Gastric Cancer_5
Aug 01
Gastric Cancer_4
Aug 01
Gastric Cancer_3
Aug 01
Gastric Cancer_2
Aug 01
Gastric Cancer_1
Aug 01
HIMALAYA 5-year Median OS Results
Jul 31
ATOMIC 10
Jul 31
ATOMIC 9
Jul 31
ATOMIC 8
Jul 31
ATOMIC 7
Jul 31
ATOMIC 6
Jul 31
ATOMIC 5
Jul 31
ATOMIC 4
Jul 31
ATOMIC 3
Jul 31
ATOMIC 2
Jul 31
ATOMIC 1
Jul 31
Imbrave-152 Negative
Jul 29
Zanidatamab + chemo in HER2+ gastric ca
Jul 22
Adjuvant therapy in BTC?
Jul 12
What’s Next?
Jul 07
Limitations and Learning
Jul 07
Observer Agreement
Jul 07
ME-OE: Better Accuracy, Sensitivity
Jul 07
Higher Yields with ME-OE
Jul 07
The Trial Design
Jul 07
Introducing ME-OE
Jul 07
White-Light Endoscopy: A Limitation?
Jul 07
The Correa Cascade
Jul 07
Why Gastric Cancer Detection Matters
Jul 07
Clinical Implications
Jul 07
Curative Conversion Therapy
Jul 07
Management of Recurrence
Jul 07
Duration of Therapy Beyond CR
Jul 07
The Validity of mRECIST in Immunotherapy
Jul 07
Survival Outcomes Following CR
Jul 07
Defining Response – RECIST vs. mRECIST
Jul 07
Patient Characteristics
Jul 07
Patient Characteristics
Jul 07
HCC and ICI therapy
Jul 07
FORTITUDE 101 positive
Jun 30
DESTINY GASTRIC -04 positive
Jun 26
TTFs in treatment of PDAC?
Jun 23
BESPOKE CRC_5
Jun 21
BESPOKE CRC_4
Jun 21
BESPOKE CRC_3
Jun 21
BESPOKE CRC_2
Jun 21
BESPOKE CRC_1
Jun 21
Loading logo